Astera Labs, Inc. Common Stock
NASDAQ:ALABSemiconductors
+$39.44 today
- Market cap
- $37.88B
- Beta
- 3.96
- P/E (TTM)
- 264.2
- EPS (TTM)
- $1.57
Volume 4.57M
Average 5.72M
ALAB Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Astera Labs, Inc. Common StockNASDAQ: ALAB
Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026
Accounts receivables turns negative
Q2 FY2026 accounts receivables was -$57.67M, compared with $45.46M a year earlier. Trailing-twelve-month accounts receivables was -$168.3M. Over 3 fiscal years it compounded at +94.4% a year.
Context
- Accounts receivables amounted to 5.2% of revenue in FY2025, down 2.5 pp from a year earlier.
- Accounts receivables increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts receivables holds near -$57.67M or moves back toward the trailing-twelve-month quarterly average of -$42.07M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (44.34M) USD
- Year-over-year change
- -45.5%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (44.34M) | -45.5% |
| FY2024 | 2024-12-31 | (30.48M) | -1377.5% |
| FY2023 | 2023-12-31 | 2.39M | +139.5% |
| FY2022 | 2022-12-31 | (6.04M) | — |
Accounts Receivables vs competitors
How ALAB compares with its peers on the latest reported figures
- ALAB's LTM Jun 2026 accounts receivables of $168.3M is the 3rd largest of the 7 companies compared; the peer median is $60.89M.
- Its year-over-year change of +7948.5% is the highest of 6, against a peer median of +120.6%.
- Accounts receivables amounts to 14.0% of revenue for ALAB, versus a peer median of 2.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Aug 2026 | $766.6M | +95.8% | +101.0% | 8.1% | |
| LTM Sep 2026 | $558M | +179.0% | +7.9% | 2.7% | |
| LTM Jun 2026 | $168.3M | +7948.5% | +94.4% | 14.0% | |
| LTM Jun 2026 | $125M | +120.6% | — | 0.7% | |
| LTM Aug 2026 | $106.24M | -2.8% | +52.4% | 6.7% | |
| LTM Sep 2026 | $15.53M | +210.4% | — | 2.4% | |
| LTM Aug 2026 | $0 | — | -35.8% | 0.0% | |
| Peer median (excluding ALAB) | $60.89M | +120.6% | +30.2% | 2.5% | |
Competitors are the stored peer set for ALAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Net Income | (58.35M) | (26.26M) | (83.42M) | 219.13M |
| Depreciation & Amortization | 807K | 1.78M | 3.15M | 6.83M |
| Deferred Income Tax | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 30.24M | 10.68M | 234.59M | 160.03M |
| Change in Working Capital | (9.97M) | (9.68M) | (13.3M) | (65.96M) |
| Accounts Receivables | (6.04M) | 2.39M | (30.48M) | (44.34M) |
| Inventory | (19.36M) | (5.56M) | (19.29M) | (12.95M) |
| Accounts Payables | 2.13M | (4.26M) | 20.89M | 14.19M |
| Other Working Capital | 13.3M | (2.23M) | 15.59M | (22.87M) |
| Other Non-Cash Items | 1.38M | 10.76M | (4.35M) | (726K) |
| Operating Cash Flow | (35.9M) | (12.72M) | 136.68M | 319.31M |
| Capital Expenditures | (3.87M) | (2.76M) | (34.25M) | (37.54M) |
| Acquisitions (Net) | 0 | 0 | 0 | (28.79M) |
| Purchases of Investments | (88.71M) | (126.23M) | (930.58M) | (857.75M) |
| Sales of Investments | 2M | 111.21M | 208.67M | 683.11M |
| Other Investing Activities | 0 | 0 | (1.41M) | (500K) |
| Investing Cash Flow | (90.59M) | (17.77M) | (757.57M) | (241.47M) |
| Debt Repayment | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 672.2M | 9.8M |
| Common Stock Repurchased | (313K) | (210K) | (1.07M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.12M | (292K) | (15.29M) | 0 |
| Financing Cash Flow | 151.67M | (502K) | 655.84M | 9.8M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 |
| Net Change in Cash | 25.18M | (30.99M) | 34.95M | 87.64M |
| Free Cash Flow | (39.77M) | (15.48M) | 102.43M | 281.76M |
Astera Labs, Inc. Common Stock
NASDAQ:ALAB
Intrinsic Alpha fair value
Locked
Current Price
$216.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.